Last update 20 Mar 2025

EP652

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Compound 56(Epics Therapeutics SA), METTL3 inhibitors(Epics Therapeutics SA)
Target
METTL3
Action
inhibitors
Mechanism
METTL3 inhibitors(methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit inhibitors)
Therapeutic Areas
Neoplasms
Active Indication
Neoplasms
Inactive Indication-
Originator Organization
Epics Therapeutics SAEpics Therapeutics SAStartup
Active Organization
Paraza Pharma, Inc.Paraza Pharma, Inc.Cresset BioMolecular Discovery Ltd.Cresset BioMolecular Discovery Ltd.Epics Therapeutics SAEpics Therapeutics SAStartup
Inactive Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Structure/Sequence

Molecular FormulaC25H34N8O
InChIKeySIMGHJKPZKGPGZ-WIYYLYMNSA-N
CAS Registry3050819-22-9

Related

100 Clinical Results associated with EP652
Login to view more data
100 Translational Medicine associated with EP652
Login to view more data
100 Patents (Medical) associated with EP652
Login to view more data
1
Literatures (Medical) associated with EP652
13 Feb 2025Journal of Medicinal Chemistry
Discovery, Optimization, and Preclinical Pharmacology of EP652, a METTL3 Inhibitor with Efficacy in Liquid and Solid Tumor Models
100 Deals associated with EP652
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
NeoplasmsPreclinical
Canada
Paraza Pharma, Inc.Paraza Pharma, Inc.
30 Jan 2025
NeoplasmsPreclinical
Belgium
Epics Therapeutics SAEpics Therapeutics SAStartup
30 Jan 2025
NeoplasmsPreclinical
United Kingdom
Cresset BioMolecular Discovery Ltd.Cresset BioMolecular Discovery Ltd.
30 Jan 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free